Treatment of Nonalcoholic Steatohepatitis With Pioglitazone

NCT00013598 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Fatty Liver
Nonalcoholic Steatohepatitis

Interventions

DRUG: Pioglitazone

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)